| NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: crystal structure of the adenylation domain and identification of novel inhibitors SK Srivastava, RP Tripathi, R Ramachandran Journal of Biological Chemistry 280 (34), 30273-30281, 2005 | 184 | 2005 |
| Emerging trends in colorectal cancer: Dysregulated signaling pathways R Ahmad, JK Singh, A Wunnava, O Al-Obeed, M Abdulla, SK Srivastava International journal of molecular medicine 47 (3), 14, 2021 | 137 | 2021 |
| Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I SK Srivastava, D Dube, N Tewari, N Dwivedi, RP Tripathi, ... Nucleic acids research 33 (22), 7090-7101, 2005 | 80 | 2005 |
| Influence of the AgrC-AgrA complex on the response time of Staphylococcus aureus quorum sensing SK Srivastava, K Rajasree, A Fasim, G Arakere, B Gopal Journal of bacteriology 196 (15), 2876-2888, 2014 | 73 | 2014 |
| NAD+‐dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: Novel structure‐function relationship and identification of a specific inhibitor SK Srivastava, D Dube, V Kukshal, AK Jha, K Hajela, R Ramachandran Proteins: Structure, Function, and Bioinformatics 69 (1), 97-111, 2007 | 61 | 2007 |
| Structural basis for dimerization and activity of human PAPD1, a noncanonical poly (A) polymerase Y Bai, SK Srivastava, JH Chang, JL Manley, L Tong Molecular cell 41 (3), 311-320, 2011 | 57 | 2011 |
| Mcl-1 inhibition: managing malignancy in multiple myeloma OS Al-Odat, M von Suskil, RJ Chitren, WO Elbezanti, SK Srivastava, ... Frontiers in pharmacology 12, 699629, 2021 | 33 | 2021 |
| Association of the microbiome with colorectal cancer development MH Abdulla, D Agarwal, JK Singh, TB Traiki, MK Pandey, R Ahmad, ... International journal of oncology 58 (5), 17, 2021 | 29 | 2021 |
| Conformational basis for substrate recognition and regulation of catalytic activity in Staphylococcus aureus nucleoside di-phosphate kinase SK Srivastava, K Rajasree, B Gopal Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1814 (10), 1349-1357, 2011 | 25 | 2011 |
| Bruton’s tyrosine kinase targeting in multiple myeloma M Von Suskil, KN Sultana, WO Elbezanti, OS Al-Odat, R Chitren, ... International journal of molecular sciences 22 (11), 5707, 2021 | 19 | 2021 |
| Handbook of oxidative stress in cancer: therapeutic aspects S Chakraborti Springer Nature, 2022 | 15 | 2022 |
| Is BF. 7 more infectious than other Omicron subtypes: Insights from structural and simulation studies of BF. 7 spike RBD variant JK Singh, S Anand, SK Srivastava International Journal of Biological Macromolecules 238, 124154, 2023 | 13 | 2023 |
| Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like … WO Elbezanti, OS Al-Odat, R Chitren, JK Singh, SK Srivastava, K Gowda, ... Frontiers in Pharmacology 13, 894535, 2022 | 11 | 2022 |
| In silico identification of ethoxy phthalimide pyrazole derivatives as IL-17A and IL-18 targeted gouty arthritis agents AK Verma, MS Hossain, SKF Ahmed, N Hussain, M Ashid, SK Upadhyay, ... Journal of Biomolecular Structure and Dynamics 41 (10), 4681-4695, 2023 | 10 | 2023 |
| Neohesperidin and spike RBD interaction in omicron and its sub-variants: In silico, structural and simulation studies JK Singh, S Dubey, G Srivastava, MI Siddiqi, SK Srivastava Computers in Biology and Medicine 152, 106392, 2023 | 9 | 2023 |
| NAD+-dependent DNA ligase (Rv3014c) from M. tuberculosis: Strategies for inhibitor design D Dube, V Kukshal, SK Srivastava, RP Tripathi, R Ramachandran Medicinal Chemistry Research 17, 189-198, 2008 | 9 | 2008 |
| Cloning, expression, purification and crystallization of a transcriptional regulatory protein (Rv3291c) from Mycobacterium tuberculosis H37Rv T Shrivastava, S Kumar, R Ramachandran Biological Crystallography 60 (10), 1874-1876, 2004 | 9 | 2004 |
| Identification of alkaloid compounds as potent inhibitors of Mycobacterium tuberculosis NadD using computational strategies AK Verma, S Dubey, SK Srivastava Computers in Biology and Medicine 158, 106863, 2023 | 8 | 2023 |
| Mycobacterium tuberculosis UsfX (Rv3287c) exhibits novel nucleotide binding and hydrolysis properties SS Malik, A Luthra, SK Srivastava, R Ramachandran Biochemical and biophysical research communications 375 (3), 465-470, 2008 | 8 | 2008 |
| Modular Diversity of the BLUF Proteins and Their Potential for the Development of Diverse Optogenetic Tools MS Kaushik, R Sharma, KV Sindhu, SK Srivastava, S Kateriya Applied Sciences 9 (18), 3924, 2019 | 7 | 2019 |
Ravishankar RamachandranProfessor, AcSIR & Chief Scientist, CSIR-Central Drug Research Institute, Indiaยืนยันอีเมลแล้วที่ cdri.res.in